# Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI

> **NCT03795038** · NA · COMPLETED · sponsor: **Fresenius Medical Care Deutschland GmbH** · enrollment: 20 (actual)

## Conditions studied

- Hypercholesterolemia, Familial
- Dyslipidemias
- Cardiovascular Diseases

## Interventions

- **DEVICE:** Lipoprotein Apheresis MONET and DALI
- **DEVICE:** Lipoprotein Apheresis DIAMED and DALI

## Key facts

- **NCT ID:** NCT03795038
- **Lead sponsor:** Fresenius Medical Care Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-28
- **Primary completion:** 2021-05-25
- **Final completion:** 2021-05-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03795038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03795038, "Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03795038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*